InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 184063

Tuesday, 05/12/2015 10:17:45 PM

Tuesday, May 12, 2015 10:17:45 PM

Post# of 345981

the bottom line, Dmitry is the MD talking MDSC's and MDSC's "CAN" predict overall survival and he starts off the video with some general talking points re: leucocytes/neutrophils .. immune system..etc before showing in various cancer indications-- its MDSC's that speak the truth about overall survival.

Do I really think the the DMC will allow SunRise to go further than it needs to, once PS Targeting is proven to fall directly inline with positioning MDSC's on that path of a positive overall survival? Nope
...
...
I believe Dmitry is playing a major role in solidifying the changes that take place regarding our immune systems and most likely this will all play a part in some blood test to test for cancer in general due to many changes... some involving white blood cells aka = leucocytes (which there are 5 types)

1) Neutrophils
2) Eosinophils
3) Basophils
4) Monocytes
5) Lymphocytes - just will expand on this for now..



if one gets confused about the various white blood cells = leucocytes, here is a short video that explains some of the functions / side effects below:

Dr. Susan Leclair explains why we should take a minute to understand eos (eosinphils), basos (basophils) and monos (monocytes) and what they indicate in your lab results. Why do basos fluctuate? Why do we see an increase in eos in some myeloproliferative diseases? Dr. Leclair gives a concise illustrative overview of these white cells and what they mean for your health and well-being.

Eosinophils, Basophils and Monocytes: What Do These Lab Results Mean?

http://www.patientpower.info/video/eosinophils-basophils-and-monocytes-what-do-these-lab-results-mean




....the above comes from "Patient Power.." and David Carbone and Scott Antonia (both Peregrine KOL's) have a couple videos each on the site:

http://www.patientpower.info/lung-cancer/understanding

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News